Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th
Newsfile Corp•27/10/2026•08:30 ET
1
Key Highlights
- ➤Envoy Medical (COCH) will report Q3 2026 financial results November 5
- ➤Conference call scheduled for 4:30 P.M. ET following results release
- ➤Acclaim cochlear implant remains an investigational device
- ➤Esteem active middle ear implant commercially available in U.S. since 2010
Management Will Host a Conference Call at 4:30 P.M. ET on the Same Day
White Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced it will report its financial results for the third quarter ended September 30, 2026, on Thursday, November 5, 2026. Following the release of its financial results, the Company will host a conference call at 4:30 P.M. ET on the same day.
Get started
Create a free account to read the full story.